HA35 clinical trials
Also written HA35.
- studies test it
- 8
- open now
- 0
- in phase 3
- 0
- first study started
- 2020
How each study uses HA35 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2023 (5)
| Year | Studies |
|---|---|
| 2020 | 2 |
| 2023 | 5 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- No phase
- 8
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 4
Nakhia Impex LLC (4) · Dove Medical Press Ltd (4)
Studies
Open first, then newest update. How each study uses HA35 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- 35 kDa Hyaluronan Fragment (HA35) Reduces Chronic Inflammation of SkinCompletedNot applicableNakhia Impex LLCNCT06387212Written as 35 kDa hyaluronan fragment HA35 injection
- Local Injection of Periodontal Pocket Method for the Treatment of GingivitisCompletedNot applicableDove Medical Press LtdNCT05812300Written as Freshly manufactured 35 kDa hyaluronan fragment
- 35kDa Hyaluronan Fragment Treatment of Colorectal and Rectal CancerCompletedNot applicableNakhia Impex LLCNCT06209970Written as HA35
- Local Injection for the Treatment of Chronic Wounds and Pain Caused by Chronic WoundsCompletedNot applicableNakhia Impex LLCNCT05810649Written as Freshly manufactured 35 kDa hyaluronan fragment
- HA35 Treatment the Gingival Discomfort as Well as Gingival Redness and Bleeding of Patients With PeriodontitisCompletedNot applicableDove Medical Press LtdNCT05765513Written as HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089)
- Injection Therapy for Neuropathic PainCompletedNot applicableDove Medical Press LtdNCT05809700Written as Freshly manufactured 35 kDa hyaluronan fragment
- Freshly Manufactured 35kDa Hyaluronan Fragment HA35 for the Treatment of Chronic WoundsCompletedNot applicableNakhia Impex LLCNCT05764226Written as HA35(L20200708MP07707, Ministry of Health, Mongolia)was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089)
- A Clinical Study of Freshly Manufactured 35kDa Hyaluronan Fragment in the Treatment of PainCompletedNot applicableDove Medical Press LtdNCT05756595Written as HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089)